Gilead’s HIV Business is Surging, but is the Company Too Dependent on One Franchise?

Reported by Yahoo Finance · Published 24 Aug 2026, 7:15 AM MYT (1 hr ago)

Summary

Source & full coverage: this summary is aggregated from Yahoo Finance, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at Yahoo Finance →

Most Recent

Samsung Electronics shares fall after shareholder return announcement 44 min ago UK fintech funding drops to lowest level in more than a decade 1 hr ago Micron, Sandisk, and SK Hynix: History Says This About the Memory Trio's Rally 1 hr ago Abbott vs. Intuitive Surgical: Which MedTech Stock Offers Better Long-Term Upside? 1 hr ago Review launched into how pub and hotel business rates calculated 1 hr ago 'I didn't speak the Queen's English': Why people worry about their accents 1 hr ago

EconPulse

Markets. Economy. Malaysia & The World.

Independent economic news aggregation for Malaysia, Asia and global markets, updated throughout the day.

Company

About Us Editorial Standards & Corrections Privacy Policy

Work With Us

Submit a Press Release Partnerships & Advertising Contact Us RSS Feed

Contact

editor@econpulse.my

Editorial & newsroom enquiries answered within 1–2 business days.

Gilead’s HIV Business is Surging, but is the Company Too Dependent on One Franchise?

Summary

More in Markets

Micron, Sandisk, and SK Hynix: History Says This About the Memory Trio's Rally

Abbott vs. Intuitive Surgical: Which MedTech Stock Offers Better Long-Term Upside?

You Can Now Deduct Car Loan Interest but Only if the Final Assembly Happened in America. Here’s How to Check If a Car Qualifies

The AI Debt Boom Is Helping Push Everyone’s Cost of Capital Higher

Pfizer’s Turnaround is Gaining Traction, but Can New Products Offset its Patent Cliff?

Retirees can supplement their Social Security with two top dividend stocks